These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27391801)

  • 1. Expression and knockdown of zebrafish folliculin suggests requirement for embryonic brain morphogenesis.
    Kenyon EJ; Luijten MN; Gill H; Li N; Rawlings M; Bull JC; Hadzhiev Y; van Steensel MA; Maher E; Mueller F
    BMC Dev Biol; 2016 Jul; 16(1):23. PubMed ID: 27391801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (FLCN).
    Lu X; Boora U; Seabra L; Rabai EM; Fenton J; Reiman A; Nagy Z; Maher ER
    Oncogene; 2014 Feb; 33(8):956-65. PubMed ID: 23416984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
    Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A
    J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birt-Hogg-Dube syndrome is a novel ciliopathy.
    Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA
    Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
    Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
    Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLCN: The causative gene for Birt-Hogg-Dubé syndrome.
    Schmidt LS; Linehan WM
    Gene; 2018 Jan; 640():28-42. PubMed ID: 28970150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.
    Nahorski MS; Lim DH; Martin L; Gille JJ; McKay K; Rehal PK; Ploeger HM; van Steensel M; Tomlinson IP; Latif F; Menko FH; Maher ER
    J Med Genet; 2010 Jun; 47(6):385-90. PubMed ID: 20522427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of
    Liu L; Yang K; Wang X; Shi Z; Yang Y; Yuan Y; Guo T; Xiao X; Luo H
    Biomed Res Int; 2017; 2017():8751384. PubMed ID: 28785590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
    BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome.
    Chu L; Luo Y; Chen H; Miao Q; Wang L; Moats R; Wang T; Kennedy JC; Henske EP; Shi W
    Thorax; 2020 Jun; 75(6):486-493. PubMed ID: 32238524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.
    Tee AR; Pause A
    Fam Cancer; 2013 Sep; 12(3):367-72. PubMed ID: 23096221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer.
    Bartram MP; Mishra T; Reintjes N; Fabretti F; Gharbi H; Adam AC; Göbel H; Franke M; Schermer B; Haneder S; Benzing T; Beck BB; Müller RU
    BMC Med Genet; 2017 May; 18(1):53. PubMed ID: 28499369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial multiple discoid fibromas: a look-alike of Birt-Hogg-Dubé syndrome not linked to the FLCN locus.
    Starink TM; Houweling AC; van Doorn MB; Leter EM; Jaspars EH; van Moorselaar RJ; Postmus PE; Johannesma PC; van Waesberghe JH; Ploeger MH; Kramer MT; Gille JJ; Waisfisz Q; Menko FH
    J Am Acad Dermatol; 2012 Feb; 66(2):259.e1-9. PubMed ID: 21794948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.
    Takagi Y; Kobayashi T; Shiono M; Wang L; Piao X; Sun G; Zhang D; Abe M; Hagiwara Y; Takahashi K; Hino O
    Oncogene; 2008 Sep; 27(40):5339-47. PubMed ID: 18663353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.
    Clausen L; Stein A; Grønbæk-Thygesen M; Nygaard L; Søltoft CL; Nielsen SV; Lisby M; Ravid T; Lindorff-Larsen K; Hartmann-Petersen R
    PLoS Genet; 2020 Nov; 16(11):e1009187. PubMed ID: 33137092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birt-Hogg-Dubé syndrome: a literature review and case study of a Chinese woman presenting a novel FLCN mutation.
    Hao S; Long F; Sun F; Liu T; Li D; Jiang S
    BMC Pulm Med; 2017 Feb; 17(1):43. PubMed ID: 28222720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting the loss of the birt-hogg-dube suppressor gene.
    Lu X; Wei W; Fenton J; Nahorski MS; Rabai E; Reiman A; Seabra L; Nagy Z; Latif F; Maher ER
    Mol Cancer Ther; 2011 Jan; 10(1):80-9. PubMed ID: 21220493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.
    Baba M; Keller JR; Sun HW; Resch W; Kuchen S; Suh HC; Hasumi H; Hasumi Y; Kieffer-Kwon KR; Gonzalez CG; Hughes RM; Klein ME; Oh HF; Bible P; Southon E; Tessarollo L; Schmidt LS; Linehan WM; Casellas R
    Blood; 2012 Aug; 120(6):1254-61. PubMed ID: 22709692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.